Avery Newman-Simmons
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Avery Newman-Simmons has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Aaron Pollett
Mount Sinai Hospital, Toronto, ON, Canada
1 shared publication - Andrea Grin
Department of Pathology and Molecular Medicine, Queen’s University, Kingston, ON K7L 3N6, Canada
1 shared publication - Carly C. Barron
Princess Margaret Cancer Centre, Toronto, ON M5G 2C4, Canada
1 shared publication - Claire Norman
School of Medicine, Queen’s University, Kingston, ON K7L 3N6, Canada
1 shared publication - Daniel Jafari
Department of Biomedical and Molecular Sciences, Queen’s University, Kingston, ON K7L 3N6, Canada
1 shared publication - Darya Ali
Department of Pathology and Molecular Medicine, Queen’s University, Kingston, ON K7L 3N6, Canada
1 shared publication
Latest Publications
- Open Access
- 9 September 2026
- Published by MDPI AG in Current Oncology
- Vol. 33 (9) , 540
Assessing Quality Gaps and Clinician Perspectives on AI Integration in Colorectal Cancer NGS Pathways
Next-generation sequencing (NGS) is integral to colorectal cancer (CRC) care, but its value depends on results being available when treatment decisions are made. We conducted a qualitative study to identify quality gaps in CRC NGS pathways and assess perspectives on digital and artificial intelligence (AI)-enabled workflow support. Semi-structured interviews were conducted with 22 medical oncologists and pathologists from 14 Ontario hospitals, and transcripts were analyzed thematically. Five themes emerged: (1) clinical indications and test ordering, where initiation was inconsistent because of unclear reflex-testing criteria, reliance on upstream clinicians, staging uncertainty, evolving indications, and funding constraints; (2) tissue, pathology, and laboratory workflow, where participants attributed bottlenecks and turnaround variability to send-out testing, staffing, infrastructure, and capacity; (3) interdisciplinary communication and tracking, where informal communication, unclear ownership, and manual tracking highlighted the need for closed-loop confirmation and alerts; (4) reporting and clinical integration, where report clarity, interpretability, and timing affected use; and (5) electronic health record integration and AI integration, where fragmented systems and limited interoperability delayed result access. Participants supported clinician-supervised digital or AI-enabled tools for case identification, triage, tracking, and overdue-result alerts. CRC NGS optimization requires standardized reflex criteria, clearer ownership, closed-loop tracking, reliable routing, structured reporting, and interoperable infrastructure.
- 9 September 2026
- Published by MDPI AG in Current Oncology
- Vol. 33 (9) , 540
Open AccessAssessing Quality Gaps and Clinician Perspectives on AI Integration in Colorectal Cancer NGS Pathways
Next-generation sequencing (NGS) is integral to colorectal cancer (CRC) care, but its value depends on results being available when treatment decisions are made. We conducted a qualitative study to identify quality gaps in CRC NGS pathways and assess perspectives on digital and artificial intelligence (AI)-enabled workflow support. Semi-structured interviews were conducted with 22 medical oncologists and pathologists from 14 Ontario hospitals, and transcripts were analyzed thematically. Five themes emerged: (1) clinical indications and test ordering, where initiation was inconsistent because of unclear reflex-testing criteria, reliance on upstream clinicians, staging uncertainty, evolving indications, and funding constraints; (2) tissue, pathology, and laboratory workflow, where participants attributed bottlenecks and turnaround variability to send-out testing, staffing, infrastructure, and capacity; (3) interdisciplinary communication and tracking, where informal communication, unclear ownership, and manual tracking highlighted the need for closed-loop confirmation and alerts; (4) reporting and clinical integration, where report clarity, interpretability, and timing affected use; and (5) electronic health record integration and AI integration, where fragmented systems and limited interoperability delayed result access. Participants supported clinician-supervised digital or AI-enabled tools for case identification, triage, tracking, and overdue-result alerts. CRC NGS optimization requires standardized reflex criteria, clearer ownership, closed-loop tracking, reliable routing, structured reporting, and interoperable infrastructure.